Key result
Angiotensin II infusion did not change papillary blood flow, but increased mean arterial pressure by 10% and decreased renal and cortical blood flow in anaesthetised Wistar rats.
Answers are grounded in this paper and cite their sources.
The increase in papillary blood flow to Ang II after enalapril treatment suggests ACE inhibitors may affect the sensitivity of renal papillary autoregulation, contributing to their blood pressure-lowering effect.
AIMS: Renal medullary blood flow is important in blood pressure regulation and is surprisingly unaffected by the vasoconstrictor action of angiotensin II (Ang II). This study tested if the effect of Ang II on the renal papillary circulation is modulated by bradykinins, prostaglandins or NO (NO). In anaesthetised Wistar rats, total renal blood flow (RBF) was measured, as was cortical (CBF) and papillary (PBF) blood flow, using the laser-Doppler technique, in responses to Ang II (30 ng kg(-1) min(-1)) alone and after ACE inhibition (enalapril) or bradykinin/prostaglandin synthesis inhibition (ketoprofen, aprotinin). PBF was also measured after blockade of NO formation with or without pretreatment with an Ang II receptor antagonist (losartan). MAJOR FINDINGS: (i) PBF did not change in response to Ang II infusion but MAP increased (+ 10%) and RBF and CBF decreased. (ii) Treatment with aprotinin and ketoprofen left MAP, RBF and CBF unchanged but decreased PBF. Ang II did not decrease PBF further but a significant increase in MAP was seen. (iii) Enalapril treatment left PBF unchanged but decreased MAP and increased RBF and CBF. When Ang II was infused PBF and MAP increased markedly. (iv) L-NAME reduced PBF independently of losartan treatment. PRINCIPAL CONCLUSION: Bradykinin and prostaglandins do not appear to cause the lack of renal papillary vasoconstriction to Ang II. However, the increase in PBF to Ang II seen after enalapril treatment suggests that enalapril treatment, possibly via its effects on kinin breakdown and subsequent NO formation, might affect the sensitivity of renal papillary autoregulation. This may be an important aspect of the blood pressure lowering effect of ACE inhibitors.
No takes yet. Share an insight, caveat, or question.
Jonas Rudenstam (2000) studied this question. Angiotensin II infusion vs. baseline and various inhibitors (enalapril, ketoprofen, aprotinin, L-NAME, losartan) was evaluated on Papillary blood flow (PBF), cortical blood flow (CBF), total renal blood flow (RBF), and mean arterial pressure (MAP). Angiotensin II infusion did not change papillary blood flow, but increased mean arterial pressure by 10% and decreased renal and cortical blood flow in anaesthetised Wistar rats.
Synapse has enriched 10 related papers. Consider them for comparative context: